ACRO 2018: Curative Treatment Improves Overall Survival in Oligometastatic Head and Neck Cancer
If findings are confirmed in a larger trial, it may mean a treatment paradigm shift
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.